147 related articles for article (PubMed ID: 6568873)
1. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
[TBL] [Abstract][Full Text] [Related]
2. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
Sone S; Poste G; Fidler IJ
J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
[TBL] [Abstract][Full Text] [Related]
3. Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.
Sone S; Okubo A; Inamura N; Nii A; Ogura T
Cancer Immunol Immunother; 1988; 27(1):33-7. PubMed ID: 3135118
[TBL] [Abstract][Full Text] [Related]
4. Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
Inamura N; Nakahara K; Kino T; Gotoh T; Kawamura I; Aoki H; Imanaka H; Sone S
J Biol Response Mod; 1985 Aug; 4(4):408-17. PubMed ID: 4031951
[TBL] [Abstract][Full Text] [Related]
5. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
Watanabe Y; Tawara S; Mine Y; Kikuchi H
J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
[TBL] [Abstract][Full Text] [Related]
6. Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
Schultz RM; Altom MG
J Immunopharmacol; 1986; 8(4):515-28. PubMed ID: 3543138
[TBL] [Abstract][Full Text] [Related]
7. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effect of vitamin A on tumoricidal activity of rat alveolar macrophages.
Tachibana K; Sone S; Tsubura E; Kishino Y
Br J Cancer; 1984 Mar; 49(3):343-8. PubMed ID: 6704311
[TBL] [Abstract][Full Text] [Related]
9. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
Dinney CP; Bucana CD; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
Cancer Res; 1991 Jul; 51(14):3741-7. PubMed ID: 1905975
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
11. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
12. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
Schroit AJ; Fidler IJ
Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
[TBL] [Abstract][Full Text] [Related]
13. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
[No Abstract] [Full Text] [Related]
14. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
Sone S; Fidler IJ
Cell Immunol; 1981 Jan; 57(1):42-50. PubMed ID: 7214534
[No Abstract] [Full Text] [Related]
15. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
16. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.
Takeno H; Okada S; Hemmi K; Aratani M; Kitaura Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2925-31. PubMed ID: 6518578
[No Abstract] [Full Text] [Related]
17. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
[TBL] [Abstract][Full Text] [Related]
18. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
[TBL] [Abstract][Full Text] [Related]
19. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
